UK agency says Pfizer breast cancer drug too expensive | Reuters

LONDON Pfizer's breast cancer drug Ibrance, or palbociclib, is too expensive to justify its use on Britain's state-run health service, the country's healthcare...

Novartis chases rivals with next wave of cancer immunotherapy | Reuters

Novartis (NOVN.S), lagging some other big drugmakers in the first wave of immunotherapy drugs that are revolutionizing cancer treatment, hopes to catch up...
- Advertisement -

Latest article

Trump renews clash with U.S. sports world

SOMERSET, N.J. (Reuters) - President Donald Trump renewed his spat with the sports world on Sunday, again calling for National Football League owners...

Novelion’s Aegerion resolves U.S. drug probes for $40 million

BOSTON (Reuters) - Aegerion Pharmaceuticals Inc will plead guilty to two misdemeanors and pay $40.1 million to resolve investigations into its marketing and...

How to Wear Booties With Skinny Jeans

There's nothing wrong with a Winter uniform when it's stylish. Relying on the same pieces that you can change up day to day...